Hyperlipoproteinemia: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) (←Redirected page to Lipoprotein disorders) |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
# | __NOTOC__ | ||
{{Hyperlipoproteinemia}} | |||
{{CMG}} | |||
==[[Hyperlipoproteinemia overview|Overview]]== | |||
==[[Hyperlipoproteinemia historical perspective|Historical Perspective]]== | |||
==[[Hyperlipoproteinemia classification|Classification]]== | |||
==[[Hyperlipoproteinemia pathophysiology|Pathophysiology]]== | |||
==[[Hyperlipoproteinemia causes|Causes]]== | |||
==[[Hyperlipoproteinemia differential diagnosis|Differentiating Hyperlipoproteinemia from other Disorders]]== | |||
==[[Hyperlipoproteinemia epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Hyperlipoproteinemia risk factors|Risk Factors]]== | |||
==[[Hyperlipoproteinemia screening|Screening]]== | |||
==[[Hyperlipoproteinemia natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | |||
== Diagnosis == | |||
[[Hyperlipoproteinemia history and symptoms|History and Symptoms]] | [[Hyperlipoproteinemia physical examination|Physical Examination]] | [[Hyperlipoproteinemia laboratory findings|Laboratory Findings]] | [[Hyperlipoproteinemia other diagnostic studies|Other Diagnostic Studies]] | |||
== Treatment == | |||
[[Hyperlipoproteinemia lifestyle modification|Lifestyle Modification]] | [[Hyperlipoproteinemia medical therapy|Medical Therapy]] | [[Hyperlipoproteinemia primary prevention|Primary Prevention]] | [[Hyperlipoproteinemia secondary prevention|Secondary Prevention]] | [[Hyperlipoproteinemia future or investigational therapies|Future or Investigational Therapies]] | |||
==Landmark Trials== | |||
==Case Studies== | |||
[[Hyperlipoproteinemia case study one|Case #1]] | |||
{{Lipopedia}} | |||
[[Category:Cardiology]] | |||
[[Category:Disease]] | |||
[[Category:Lipopedia]] | |||
[[Category:Lipids]] | |||
[[Category:Up-To-Date]] | |||
{{WH}} | |||
{{WS}} | |||
Revision as of 12:27, 17 September 2013
|
Hyperlipoproteinemia Microchapters |
|
ACC/AHA Guideline Recommendations |
|
Intensity of statin therapy in primary and secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hyperlipoproteinemia from other Disorders
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies
Treatment
Lifestyle Modification | Medical Therapy | Primary Prevention | Secondary Prevention | Future or Investigational Therapies